(Q36721130)

15 August 2017

Profound hypotension after the first dose of ketanserin (English)

1 reference

15 August 2017

Waller PC

1

1 reference

15 August 2017

Cameron HA

series ordinal

2

1 reference

15 August 2017

Ramsay LE

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 April 1987

1 reference

Postgraduate Medical Journal

15 August 2017

1 reference

15 August 2017

63

1 reference

15 August 2017

738

1 reference

15 August 2017

305-307

1 reference

Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

If nothing goes wrong, is everything all right? Interpreting zero numerators

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Mechanism of antihypertensive action of ketanserin in man

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Ketanserin in essential hypertension: a double-blind, placebo-controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Comparison of single doses of ketanserin and placebo in chronic stable angina

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Side effects due to treatment of hypertension with prazosin

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428148

Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist

28 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3684842

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/PGMJ.63.738.305

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

3684842

1 reference